Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 83 references it cites were found in a registry or an index; 20 of the 67 sources its claims cite were checked for support.

Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial

Open access
Bais, Babette, Kamperman, Astrid M, Bijma, Hilmar H, Hoogendijk, Witte JG, Souman, Jan L, Knijff, Esther, Lambregtse-van den Berg, Mijke P · 2020 · BMJ Open

Abstract

Objectives: Approximately 11%–13% of pregnant women suffer from depression. Bright light therapy (BLT) is a promising treatment, combining direct availability, sufficient efficacy, low costs and high safety for both mother and child. Here, we examined the effects of BLT on depression during pregnancy. Design: Randomised, double-blind controlled trial. Setting: Primary and secondary care in The Netherlands, from November 2016 to March 2019. Participants: 67 pregnant women (12–32 weeks gestational age) with a DSM-5 diagnosis of depressive disorder (Diagnostic and Statistical Manual of Mental Disorders). Interventions: Participants were randomly allocated to treatment with either BLT (9000 lux, 5000 K) or dim red light therapy (DRLT, 100 lux, 2700 K), which is considered placebo. For 6 weeks, both groups were treated daily at home for 30 min on awakening. Follow-up took place weekly during the intervention, after 6 weeks of therapy, 3 and 10 weeks after treatment and 2 months postpartum. Primary and secondary outcome measures: Depressive symptoms were measured primarily with the Structured Interview Guide for the Hamilton Depression Scale—Seasonal Affective Disorder. Secondary measures were the Hamilton Rating Scale for Depression and the Edinburgh Postnatal Depression Scale. Changes in rating scale scores of these questionnaires over time were analysed using generalised linear mixed models. Results: Median depression scores decreased by 40.6%–53.1% in the BLT group and by 50.9%–66.7% in the DRLT group. We found no statistically significant difference in symptom change scores between BLT and DRLT. Sensitivity and post-hoc analyses did not change our findings. Conclusions: Depressive symptoms of pregnant women with depression improved in both treatment arms. More research is necessary to determine whether these responses represent true treatment effects, non-specific treatment responses, placebo effects or a combination hereof. Trial registration number: NTR5476.

Overview

CoChat Summary

TL;DR

In this randomized, double-blind trial of 67 pregnant women with DSM-5 depressive disorder, 6 weeks of bright light therapy (9000 lux) did not outperform dim red light therapy (100 lux) for depressive symptoms. Symptoms improved substantially in both arms, and the authors conclude more research is needed to distinguish true treatment effects from nonspecific or placebo responses.

Key findings

  • No statistically significant difference was found between BLT and DRLT on the primary SIGH-SAD outcome: intervention-period β=−0.68 (95% CI −1.84 to 0.49); entire-study β=−0.16 (95% CI −0.82 to 0.51). Secondary HAM-D and EPDS outcomes were also null.
  • Median depression scores decreased during the intervention by 42.6% (SIGH-SAD), 53.1% (HAM-D), and 40.6% (EPDS) in the BLT group, versus 50.9%, 66.7%, and 59.4% in the DRLT group; the abstract reports ranges of 40.6%–53.1% for BLT and 50.9%–66.7% for DRLT.
  • Responder rates were 13 BLT vs 17 DRLT on HAM-D (p=0.46) and 11 vs 9 on EPDS (p=0.60). Side effects were not more common with BLT than DRLT (p=0.52); headaches were reported by 30.3% of BLT and 20.6% of DRLT participants.
  • At 2 months postpartum, BLT showed no increase in EPDS scores, whereas DRLT showed an increase; SIGH-SAD and HAM-D scores decreased in both arms.

Methods

  • Randomized, double-blind, placebo-controlled trial in primary and secondary care in The Netherlands from November 2016 to March 2019. Participants were 67 pregnant women at 12–32 weeks gestational age with a DSM-5 depressive disorder, randomized 1:1 to BLT (9000 lux, 5000 K) or DRLT (100 lux, 2700 K), 30 min daily on awakening for 6 weeks, with follow-up weekly during treatment, after treatment, and up to 2 months postpartum.
  • Primary outcome was SIGH-SAD; secondary outcomes were 17-item HAM-D and EPDS. Changes over time were analyzed with general linear mixed models using intention-to-treat, including time, allocation, time×allocation, and baseline score; adjusted analyses used propensity scores, chronotype, and month of treatment, with sensitivity analyses using last observation carried forward and post-hoc analyses for compliance and baseline severity.
  • The sample size calculation required 126 participants (63 per arm), and the study aimed to include 150; inclusion stopped at 67 due to limited resources.

Limitations

  • Stated: an unforeseen lack of resources prevented inclusion of 150 participants, so the study could detect only large treatment effects; depressive symptoms were assessed by questionnaires rather than diagnostic criteria; psychiatric history was collected by interview rather than medical records, risking recall bias; several covariates were self-reported; and differential attrition occurred at 10 weeks after treatment and 2 months postpartum, though sensitivity analyses were reported as robust.
  • Evident: the final sample of 67 was substantially below the planned 126–150, leaving it underpowered for small-to-medium effects; the field researcher who delivered the lamps was not blinded to allocation, although outcome assessors and the primary statistician were blinded; and treatment compliance was self-reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2020-038030

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flow-chart of the Bright Up Study. BLT, bright light therapy; DRLT, dim red light therapy; DSM, Diagnostic and Statistical Manual of Mental Disorders.
Figure 1 Flow-chart of the Bright Up Study. BLT, bright light therapy; DRLT, dim red light therapy; DSM, Diagnostic and Statistical Manual of Mental Disorders.CC BY · PubMed Central
Figure 2 Estimated marginal means of depression scores in women with antepartum depression until 2 months postpartum. Shown are SIGH-SAD, HAM-D and EPDS Scores. Black lines represent treatment with BLT, grey lines with DRLT. Bars represent SE of the mean. BLT, bright light therapy; DRLT, dim red light therapy; EPDS, Edinburgh Postnatal Depression Scale; HAM-D, Hamilton Rating Scale for Depression; SIGH-SAD, Structured Interview Guide for the Hamilton Depression Scale—Seasonal Affective Disorder version. T0, baseline, before treatment; T0+1, T0+2 … T0+5, weeks during intervention period; T1, end of treatment; T2, 3 weeks after end of treatment; T3, 10 weeks after end of treatment; P1, 2 months postpartum.
Figure 2 Estimated marginal means of depression scores in women with antepartum depression until 2 months postpartum. Shown are SIGH-SAD, HAM-D and EPDS Scores. Black lines represent treatment with BLT, grey lines with DRLT. Bars represent SE of the mean. BLT, bright light therapy; DRLT, dim red light therapy; EPDS, Edinburgh Postnatal Depression Scale; HAM-D, Hamilton Rating Scale for Depression; SIGH-SAD, Structured Interview Guide for the Hamilton Depression Scale—Seasonal Affective Disorder version. T0, baseline, before treatment; T0+1, T0+2 … T0+5, weeks during intervention period; T1, end of treatment; T2, 3 weeks after end of treatment; T3, 10 weeks after end of treatment; P1, 2 months postpartum.CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 2 Not valid · 27 Not checked · 86 Own results and interpretations

50 more claims · 5 with their cited sources checked

Create a free account to see all 132 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 50
  • It may state two separate claims as one. 48
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

3 of 3

Citations

Cites

Show all 83 references

Cited by

See all 24

Metadata

Authors
Bais, B., Kamperman, A. M., Bijma, H. H., Hoogendijk, W. J., Souman, J. L., Knijff, E., & Lambregtse-van den Berg, M. P.
Affiliations
  • Erasmus MC (NL)
  • Signify (Netherlands) (NL)
Corresponding author
Bais, Babette
Venue
BMJ Open
Publisher
BMJ
Published
2020-10
Volume
10
Issue
10
Pages
e038030
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3095381367
Cited by
24
References
83
Citations by year
2026: 1 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 3 · 2021: 2
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • HighWire Press Open Archive (submittedVersion)
Funders
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (058-14-003)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy-related medical research
Keywords
bright light therapy, antenatal depression, perinatal depression, placebo effect, postpartum depression, depressive symptoms
MeSH terms
Adult, Depression, Double-Blind Method, Female, Humans, Netherlands, Phototherapy, Pregnancy, Pregnancy Complications, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial. https://app.cochat.ai/papers/10.1136/bmjopen-2020-038030
The paper
Bais, B., Kamperman, A. M., Bijma, H. H., Hoogendijk, W. J., Souman, J. L., Knijff, E., & Lambregtse-van den Berg, M. P. (2020). Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2020-038030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.